Practical Journal of Organ Transplantation(Electronic Version) ›› 2022, Vol. 10 ›› Issue (5): 408-412.DOI: 10.3969/j.issn.2095-5332.2022.05.006

Previous Articles     Next Articles

Analysis of risk factors for post-transplant diabetes mellitus after kidney transplantation 

Luo Dengke1 , Chen Jin2 , Jiang Hongtao1 , Wang Yi 2 .    

  1. 1.Department of Transplantation,The Second Affiliated Hospital of Hainan Medical University,Haikou 570100,Hainan,China;

    2.The Transplantation Institute of Hainan Medical University Haikou 570100,Hainan,China.

  • Online:2022-09-20 Published:2022-09-20

肾移植后糖尿病危险因素分析

罗登科 1 ,陈津 2 ,蒋鸿涛 1 ,王毅 2    

  1. 1. 海南医学院第二附属医院器官移植科,海南海口 570100 ;

    2. 海南医学院移植医学研究所,海南 海口 570100

  • 基金资助:

    海南省科技厅重大科技计划项目(ZDKT2019009)

Abstract:

Objective To explore the risk factors of post-transplant diabetes mellitus (PTDM) in patients with kidney transplantation, to provide evidence for the prevention and treatment of PTDM. Methods Theclinical data of 136 patients who underwent allogeneic kidney transplantation from July 2018 to July 2020 were retrospectively analyzed. The patients were divided into PTDM group (fasting blood glucose ≥ 7.0 mmol/L) andnon-PTDM group (fasting blood glucose 7.0 mmol/L) according to the domestic diabetes diagnostic criteria. Univariate and multivariate Logistic regression were used to analyze the independent risk factors of PTDM. Results Among136 renal transplant patients47 cases were diagnosed with PTDM, and the incidence of PTDM was 34.6%. MultivariateLogistic regression analysis showed: age ≥ 45 years old(OR 3.019,95% CI 1.123 ~ 8.115,P 0.028), body mass index (BMI≥ 25 kg/m2 (OR 3.868,95% CI 1.253 ~ 11.941,P 0.019), acute rejection after transplantation (OR 4.620,95% CI = 1.339 ~ 15.940,P = 0.015), use of tacrolimus after transplantation (OR = 4.853,95% CI = 1.49 ~ 15.807,P = 0.009) were independent risk factors for PTDM after kidney transplantation (OR > 1,P < 0.05). ConclusionThe risk of PTDM increased significantly in kidney transplant patients with age ≥ 45 years old, BMI ≥ 25 kg/m2 , acute rejection after transplantation and use of tacrolimus after transplantation. 

Key words:

 , Post-transplant diabetes mellitus; , Kidney transplantation; , Risk factors; , Calcineurin inhibitors

摘要:

目的 探讨肾移植患者术后并发移植后糖尿病(post-transplant diabetes mellitus,PTDM)的危险因素,为 PTDM 的预防与治疗提供依据。方法 回顾性分析 2018 年 7 月至 2020 年 7 月行同种异体肾移植术的 136 例患者的临床资料。按国内糖尿病诊断标准将患者分为 PTDM 组(空腹血糖≥ 7.0 mmol/L)和non-PTDM 组(空腹血糖< 7.0 mmol/L),采用单因素和多因素 Logistic 回归分析影响 PTDM 发生的独立危险因素。结果 136 例同种异体肾移植患者中,47 例发生 PTDM,PTDM 发生率为 34.6%。多因素 Logistic回归分析显示,年龄≥ 45 岁(OR 3.019,95% CI 1.123 ~ 8.115,P 0.028)、体重指数(body massindex ,BMI≥ 25 kg/m2 (OR 3.868,95% CI 1.253 ~ 11.941,P 0.019)、移植后发生急性排斥反应(OR 4.620,95% CI 1.339 ~15.940,P 0.015)、移植后使用他克莫司(OR 4.853,95% CI 1.49 ~15.807,P 0.009)均为肾移植术后发生 PTDM 的独立危险因素(OR 1,P 0.05)。结论 年龄≥ 45 岁、BMI ≥ 25 kg/m2 、移植后发生急性排斥反应、移植后使用他克莫司的肾移植患者术后发生 PTDM 的风险明显增加。

关键词:

移植后糖尿病 , 肾移植 , 危险因素 , 钙调磷酸酶抑制剂